好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Infliximab Associated Motor Neuropathy Typically Has Monophasic Improving Course with Drug Discontinuation
Peripheral Nerve
(-)
006
Authors/Disclosures
Steven C. Kosa, MD, FAAN (Meritas Health Neurology) Dr. Kosa has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AbbVie. Dr. Kosa has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eli Lily . Dr. Kosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Impel. Dr. Kosa has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven/Pfizer. Dr. Kosa has received research support from Eli Lily .
Christopher J. Klein, MD, FAAN (Mayo Clinic) Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo Therapeutics . Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma.
James Conners, MD (Rush University Medical Center) The institution of Dr. Conners has received research support from nih.